logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cancer Informatics Essential Technologies For Clinical Trials 1st Edition John S Silva

  • SKU: BELL-4493638
Cancer Informatics Essential Technologies For Clinical Trials 1st Edition John S Silva
$ 31.00 $ 45.00 (-31%)

5.0

30 reviews

Cancer Informatics Essential Technologies For Clinical Trials 1st Edition John S Silva instant download after payment.

Publisher: Springer Science & Business Media
File Extension: PDF
File size: 7.41 MB
Pages: 377
Author: John S. Silva, Marion J. Ball, Christopher G. Chute, Judith V. Douglas, Curtis P. Langlotz, Joyce C. Niland, William L. Scherlis
ISBN: 9781461265474, 9781461300632, 1461265479, 1461300630
Language: English
Year: 2012
Edition: 1

Product desciption

Cancer Informatics Essential Technologies For Clinical Trials 1st Edition John S Silva by John S. Silva, Marion J. Ball, Christopher G. Chute, Judith V. Douglas, Curtis P. Langlotz, Joyce C. Niland, William L. Scherlis 9781461265474, 9781461300632, 1461265479, 1461300630 instant download after payment.

Cancer Informatics chronicles the development of the National Cancer Institute's new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure information exchange, and improve patient care. The book details the challenges involved in creating and managing such a knowledge base, including technologies, standards, and current, state-of-the-art applications. The ultimate goal of CII is to function as an enabler of clinical trials, expediting the clinical trials lifecycle, faciliating faster and safer drug development and more appropriate treatment choices for cancer patients. Contributors address the role the CII must play in converting the growing knowledge of genes, proteins, and pathways into appropriate preventative, diagnostic, and therapeutic measures. Presented in four sections, the first provides an overview of the processes involved in moving the infrastructure for cancer from theory into practice. Sections two through four offer the latest work done in the areas of technology, cancer-specific and national standards, and applications to faciliate clinical trials.

Related Products